Evaluation 19 ^th International Symposium on Neuropsychiatry & HIV

Practical focus on the diagnosis and treatment of the psychiatric and neuropsychological aspects of HIV infection

User information

Last name

First name

Please provide rating based upon a 5-point Likert scale (5 strongly agree, 1 strongly disagree)

Professional data

Country

City/Town

Speciality

Age

Full evaluation of Symposium. Please

Please provide rating based upon a 5-point Likert scale (5 strongly agree, 1 strongly disagree)

Full evaluation of Symposium

5 4 3 2 1

The topics are appropriate

5 4 3 2 1

The education will be useful for my work

5 4 3 2 1

The Symposium has satisfied my expectations

5 4 3 2 1

Balanced and scientifically supported information

5 4 3 2 1

Did all the faculty members provide their potential conflict of interest declaration with the sponsor(s) as a second slide of their presentation?

5 4 3 2 1

Do you agree that the information was overall free of commercial and other bias?

5 4 3 2 1

Impact

I intend to modify/change my clinical practice based on this educational activity

5 4 3 2 1

My office and practice systems can accommodate these changes

5 4 3 2 1

My patients can accommodate these changes

5 4 3 2 1

Patient access to the treatments provided will be a barrier to implementing these changes

5 4 3 2 1

On average, I utilized the patient treatment strategies described in this educational activity prior to my participation

5 4 3 2 1

Organization

The program is well organized

5 4 3 2 1

The length of the Symposium is correct

5 4 3 2 1

Discussion, questions & answers and learner engagement time is enough

5 4 3 2 1

The timetable is suitable

5 4 3 2 1

The virtual experience and quality of transmission

5 4 3 2 1

Communication

You knew about the Symposium through

The information received before the Symposium is enough

Yes No

Friday, April 24 - State of the art course for continuous education

Course Session

Course session 1: Early-Stage Age-Related Cognitive Impairment

1.A Clinical psychology perspective

José A. Muñoz-Moreno Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

1.B Clinical neurology perspective.

Neus Falgàs M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Course session 2: Psychiatric Contributors to Neurocognitive Impairment

2.A How psychosis influences

Eduard Parellada M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

2.B How major depression influence

Narcís Cardoner M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Course session 3: Menopause: Medical and psychiatric perspectives

3.A Medical perspective

Karoline Aebi-Popp PD, M.D., M.Sc.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

3.B Psychiatric perspective

Judith Usall M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Course session 4: Addressing Fatigue and Insomnia in People Living with HIV

4.A Medical and systemic perspective

Joaquim Fernández-Solà M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

4.B Clinical and neurological perspective

Alan Winston M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Course session 5: The use of patient-reported outcome measures (PROMs)

5.A Digital tools, measurement science, and methodological frameworks

Carme Carrión Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

5.B Clinical application, real-world translation, and the specific implications of PROMs for HIV care

Alfonso Cabello M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Rountable 1: Anxiety, the neglected sibling of depression

Community perspective – “what I feel”

Mr. Ben Collins

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

HIV physician perspective – “what can I do?”

Esteban Martínez M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Psychiatrist perspective – “what should be done”

Guida da Ponte M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Open comment:

Clinical Case Session

A. Toxic Encephalopathy After Chemsex in a person living with HIV

Alexy Inciarte M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

B. Neuropsychiatric comorbidities in a person living with HIV

Elizabeth Zamora M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

C. A Rare Case of Foreign Accent Syndrome in a Complex HIV Patient Successfully Treated with Pro Re Nata Benztropine

John H. Wells M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Plenary lecture

Global mental health

Milton Wainberg M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Saturday, April 25 - Update for specialist and experts in research and clinical management of mental health aspects of HIV infection

Roundtable 2: Antiretroviral therapy and the CNS: The good, the bad and what's next

Community perspective

Félix Pérez-Tejera Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Pharmacological issues

Catia Marzolini Pharm.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Clinical impact

Scott Letendre M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Open comment:

Viral persistence in the CNS and neuropathogenesis

Basic science for non-experts

Sarah Joseph M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Clinical impact

Andrea Calcagno M.D., DTM&H

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Other CNS infections and comorbidities (Long-Covid, PML, herpesvirus)

Long COVID

Lourdes Mateu M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Progressive Multifocal Leukoencephalopathy

Paola Cinque M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Psychoactive substances and neurocognitive health.

Clinical and neurocognitive impact of psychoactive substances in PLWH

Lorena de la Mora M.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Action of psychedelic substances: how they can help in therapeutic use in mental health

Santiago Madero M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Comments

Symposium aspects to emphasize

Symposium aspects to improve

Proposal: interesting topics for the next edition

Observations and suggestions

Signature

Data

To sign on your desktop you can sign with your mouse.

To sign on your mobile or tablet you can sign with the same finger.

Signature

I have read and agree to the Privacy Policy.

The form has been sent successfully.

An error occured.

🕐 Please do not close or reload this page until the thank-you page has fully loaded.

Evaluation 19 th International Symposium on Neuropsychiatry & HIV

User information

Professional data

Full evaluation of Symposium. Please

Contents

Impact

Organization

Communication

Friday, April 24 - State of the art course for continuous education

Course Session

Course session 1: Early-Stage Age-Related Cognitive Impairment

1.A Clinical psychology perspective

1.B Clinical neurology perspective.

Course session 2: Psychiatric Contributors to Neurocognitive Impairment

2.A How psychosis influences

2.B How major depression influence

Course session 3: Menopause: Medical and psychiatric perspectives

3.A Medical perspective

3.B Psychiatric perspective

Course session 4: Addressing Fatigue and Insomnia in People Living with HIV

4.A Medical and systemic perspective

4.B Clinical and neurological perspective

Course session 5: The use of patient-reported outcome measures (PROMs)

5.A Digital tools, measurement science, and methodological frameworks

5.B Clinical application, real-world translation, and the specific implications of PROMs for HIV care

Rountable 1: Anxiety, the neglected sibling of depression

Community perspective – “what I feel”

HIV physician perspective – “what can I do?”

Psychiatrist perspective – “what should be done”

Clinical Case Session

A. Toxic Encephalopathy After Chemsex in a person living with HIV

B. Neuropsychiatric comorbidities in a person living with HIV

C. A Rare Case of Foreign Accent Syndrome in a Complex HIV Patient Successfully Treated with Pro Re Nata Benztropine

Plenary lecture

Global mental health

Saturday, April 25 - Update for specialist and experts in research and clinical management of mental health aspects of HIV infection

Roundtable 2: Antiretroviral therapy and the CNS: The good, the bad and what's next

Community perspective

Pharmacological issues

Clinical impact

Viral persistence in the CNS and neuropathogenesis

Basic science for non-experts

Clinical impact

Other CNS infections and comorbidities (Long-Covid, PML, herpesvirus)

Long COVID

Progressive Multifocal Leukoencephalopathy

Psychoactive substances and neurocognitive health.

Clinical and neurocognitive impact of psychoactive substances in PLWH

Action of psychedelic substances: how they can help in therapeutic use in mental health

Comments

Signature

Evaluation 19 ^th International Symposium on Neuropsychiatry & HIV